Effective control of terminal cancer pain is usually associated with a higher incidence of toxicities or complications. Intrathecal injection of cold normal saline offers a good option. It is easy to perform, provides good pain-relief, is cost effective, and is well accepted by patients. It can be repeated if necessary and is free from complications associated with the Intrathecal use of neurolytic agents. It is recommended for greater use in patients with terminal cancer even in smaller hospitals.